Stroke
Conditions
Interventions
The participants of the study will be divided into 3 groups:
Group A (Task-Oriented Repetitive Therapy) - 10 participants
Participants in this group will receive repetitive task-oriented therapy thr
divided into 2 to 3 tasks on the first day to be repeated on the 3rd / 5th / 7th / 9th day of treatment, and 2 or 3 on the second day to be repeated on the 4th / 6th / 8th / 10th treatment.
Group B (
Other
Sponsors
Associação de Assistência à Criança Deficiente
Universidade Federal de São Carlos
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: older than 18 years; medical diagnosis of stroke with more than 6 months of injury; clinically stable; asymmetry in the functional use of the upper limbs, determined by the motor activity log scale, quantity subscale with value less than 3; classified as grade 2 or 3 according to the presence of active motor function of the affected upper limb according to the functional level scale of the University of Alabama research group; be able to perform the first four items of the wolf motor functional test; have agreed and signed the Free and Informed Consent Form.
Exclusion criteria
Exclusion criteria: pain that interferes with therapy and home activities; more than two consecutive absences during the protocol; participants who do not comply with the proposed protocol of each group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome expected 1: Score above 3 on the Motor Activity Log scale, amount of use scale (AOU), considering the pre-treatment and after 6 months of the same. The results of groups B and C are expected to be higher than group A. Motor Activity Log-Brazil (MAL): developed by Uswatte et al. (2005), consists of 30 items that assess, through two subscales, the amount of use of the affected upper limb (AOU) and patient perception about the quality of use (QOU) of the affected upper limb movement outside the therapeutic environment. The score in each item of the scale ranges from zero to five points, and in the AOU, zero indicates non-use of the arm and five-use of the affected arm as frequently as before the stroke. In QOU, zero indicates that the affected arm was not used in any way during the activity and five, as good use of the affected arm as before the stroke. In both subscales, the score is defined by the patient. The scale had its psychometric properties and cross-cultural adaptation performed by Saliba et al. (2011). (APPENDIX B);Primary Founded outcome 1: Participants presented the following averages on the MAL, amount of use scale (AOU): Group A: pretreatment (1.22); follow-up 6 months (1.68) Group B: pretreatment (1.21); follow-up 6 months (3.76) Group C: pre-treatment (1.63); follow-up 6 months (3.59);Primary outcome expected 2: change over the minimum change detectable in the Canadian Occupational Performance Measure and maintenance of outcomes up to 6 months post intervention, for both satisfaction (2.7) and performance (1.7) (Cup et al., 2003). The results of groups B and C are expected to be higher than group A. Canadian Occupational Performance Measure (COPM): developed by McColl et al. (2000) is characterized by an individualized measure, performed through a semi-structured interview, in which the patient scores the most important activities in his/her daily life that is in difficulty. After surveying the main activities, the patient attributes | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected secondary outcome 1: change in the minimum change detectable in the Wolf Motor Functional Test scale (16%) (Wolf et al., 2001) and maintenance of the results up to 6 months after the intervention. The results of groups B and C are expected to be higher than group A. Wolf Motor Function Test (WMFT): developed by Morris et al. (2001), it is a test that measures fine and gross motor skills determined by the speed of movement (seconds) on 15 functional tasks (14 uni manuals of a bimanual). The patient has 120 seconds to perform each task, with three attempts for each. If the patient can not perform a task, the score is given for 121 seconds. This scale had its reliability tested by Pereira et al. (2011). (APPENDIX C);Secondary outcome found 1: Participants presented the following averages on the WMFT scale: Group A: pretreatment (14.40); follow-up 6 months (11,10). Minimum detectable change: 23% Group B: pretreatment (13,12); follow-up 6 months (4,12). Minimum change detectable: 69% Group C: pretreatment (15,76); follow-up 6 months (8.53). Minimum change detectable: 46%;Expected outcome 2: gain of muscle strength for the movements of palmar grip and pinch grasp, as well the maintenance of these results for up to 6 months after the intervention. The results of groups B and C are expected to be higher than group A. Muscle strength tests: the forces of palmar grip and pinch grasp will be evaluated through the use of a mechanical dynamometer (Jamar® and Pinch Gauge®), where the score is analyzed in Kg / F.;Secondary outcome found 2: Due to the important heterogeneity presented among the participants, since muscle strength can differ significantly between people in normal situations. Then we used the reference value of the least affected member, that is, how much we would expect him to get under normal circumstances. In this way, it was possible to normalize the results obtained by the reference value, in which we divided the results obtained during the pre, | — |
Countries
Brazil
Contacts
Public ContactRafael Garcia
Universidade Federal de São Carlos
Outcome results
None listed